Among Android phones connecting to Starlink, a third are on AT&T. Only 2.2% are on Verizon, likely because they already have ...
Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies, a breakthrough that could lead to ...
A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...
Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...
Researchers at Cincinnati Children’s Hospital Medical Center, in collaboration with Roche, have developed a next-generation ...
News-Medical.Net on MSN
Microarray platform could help predict immune‐mediated drug‐induced liver injury
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...
Monday’s flight featured a successful deployment of simulated Starlink satellites. SpaceX will now move on to testing a more ...
One woman who suffered debilitating symptoms for 14 years before she finally received a diagnosis described the news as 'life ...
Canonization of the Roman Catholic Saint Carlo shines a spotlight on the near cure of acute promyelocytic leukemia — a rare, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results